Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jae Woo Song
AddedMar 31, 2024
UpdatedMay 31, 2026
Jae Woo Song

Jae Woo Song

Founder, Mint Venture Partners

Crunchbase

Jae Woo Song's Career

Mint Venture Partners
Mint Venture Partners

Seoul, Seoul, KR

Founder
Key Proteo
Key Proteo

Seattle, WA, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jae Woo Song's Career

Mint Venture Partners
Mint Venture Partners
Investment Firm92020Seoul, Seoul, KR
Founder

Similar to Mint Venture Partners

Mint VenturesMint VenturesCayman, Puno, PEest. 2021Mint VenturesCayman, Puno, PE · est. 2021

Mint Ventures: A research-driven venture firm specializing in funding early-stage blockchain and crypto startups.

15
M Venture PartnersM Venture PartnersSingapore, Singapore, SGest. 2019M Venture PartnersSingapore, Singapore, SG · est. 2019

Investing in disruptive start-ups across Asia.

13
Digital Healthcare PartnersDigital Healthcare PartnersSeoul, Seoul, KRest. 2016Digital Healthcare PartnersSeoul, Seoul, KR · est. 2016

South Korea's premier healthcare startup accelerator, incubating early-stage digital health ventures.

30
Mintian CapitalMintian CapitalNew York City, NY, USest. 2018Mintian CapitalNew York City, NY, US · est. 2018

Mintian Capital: NYC-based financial services firm specializing in early-stage tech investments.

50
Key Proteo
Key Proteo
$3M62019Seattle, WA, US
Founder

Similar to Key Proteo

Spear BioSpear BioBoston, MA, USProtein Assaysest. 2021Spear BioBoston, MA, US · est. 2021

Spear Bio: Empowering patients and researchers with ultra-sensitive protein assays.

16
ProteogenixProteogenixCosta Mesa, CA, USDiagnostic Testsest. 2002ProteogenixCosta Mesa, CA, US · est. 2002

ProteoGenix Inc. develops and commercializes diagnostic tests for pregnancy-related complications.

$39.2M30
ProteoWiseProteoWiseBranford, CT, USProteomics Solutionsest. 2018ProteoWiseBranford, CT, US · est. 2018

ProteoWise: Revolutionizing proteomics with high-throughput, cost-effective solutions from Yale scientists.

$8.9M6
ProteoNovaProteoNovaPasadena, CA, USDrug Developmentest. 2000ProteoNovaPasadena, CA, US · est. 2000

ProteoNova's AcPET system: a disruptive technology reducing cost and time in drug development.

$1.5M30

People Similar to Jae Woo Song

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakChi-hyung SongChi-hyung SongCo-Founder · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · DunamuBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailBobby ChaoBobby ChaoCo-Founder · DragonVentureScott BoothScott BoothCo-Founder · Lead Edge CapitalMichael BankMichael BankCo-Founder · BlipHenry WongHenry WongBoard Member · Diamond TechVenturesJiancong XiaoJiancong XiaoCo-Founder · Everest Venture CapitalCharles HudsonCharles HudsonFounder · Precursor Ventures